The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type 2 diabetes: A patient-level meta-analysis of EDITION 2 and 3

• Jean-François Yale ,

  Roles Validation, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: jean-francois.yale@mcgill.ca

  Affiliation Department of Medicine, McGill University, Montreal, Canada

  http://orcid.org/0000-0002-7833-9050

  ⨯
• Jeremy Hodson Pettus,

  Roles Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Department of Endocrinology, University of California, San Diego, United States of America

  ⨯
• Miguel Brito-Sanfiel,

  Roles Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation University Hospital Puerta de Hierro, Majadahonda, Spain

  ⨯
• Fernando Lavalle-Gonzalez,

  Roles Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation University Hospital, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Mexico

  ⨯
• Ana Merino-Trigo,

  Roles Conceptualization, Formal analysis, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Sanofi, Paris, France

  ⨯
• Peter Stella,

  Roles Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Sanofi, Paris, France

  ⨯
• Soazig Chevalier,

  Roles Conceptualization, Formal analysis, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Sanofi, Chilly-Mazarin, France

  ⨯
• Raffaella Buzzetti

  Roles Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy

  ⨯